Faruk Orge, MD
- Medical Director for Quality, Eye Institute
- Assistant Professor
Faruk H. Örge MD, FAAO, FAAP, is the William R. and Margaret E. Althans Chair and Professor in Pediatric Ophthalmology, Professor of Ophthalmology and Pediatrics at Case Western Reserve University and director of Pediatric Ophthalmology and Adult Strabismus at University Hospitals Rainbow Babies & Children’s Hospital. After completing a two-year research fellowship, internship, residency, and a clinical fellowship at Indiana University, Dr. Örge returned to his native country, Turkey, to join the faculty at Yeditepe University. He has been at UH Rainbow Babies & Children’s Hospitals since 2007.
Dr. Örge is widely recognized for his clinical expertise and is listed in the Best Doctors of America (since 2009), Top Doctors (since 2011), and Who’s Who (2014). Dr. Örge has served on and led many committees (Online, Public Education, Program committees) of the American Association of Pediatric Ophthalmology and has joined the AAPOS Board of Directors in 2018 as a director at large. He is an examiner for the American Board of Ophthalmology and serves as the AAPOS liaison to the ABO. He is currently the fellowship program director and the UH Eye Institute residency associate director. His innovations in teaching include work with ORBIS/Cyber-sight, AAPOS, and the AAO, with interests in telemedicine, live webinars (first to produce national and international sessions in the field of ophthalmology), online journal clubs, and unique learning tools such as an interactive strabismus and retinoscopy simulators. He is the editor-in-chief for the AAO’s newly formed KTEF Pediatric Ophthalmology Education Center; the largest online educational source in the world for pediatric ophthalmology and strabismus, it has been visited more than 1 million times from more than 200 countries since its inception in 2015.
Dr. Örge’s research interests comprise almost all aspects of pediatric ophthalmology (ocular imaging, drug release, ROP, glaucoma, microsurgery, cataract, genetic conditions, eyelid trauma, consultation, sedation, strabismus, nystagmus, amblyopia, etc.) His dedication to research and clear direction resulted him being awarded grants including the prestigious Knights Templar Eye Foundation Research Grant for his project in retinopathy of prematurity (ROP), Cleveland Foundation grants (New glaucoma device formation, suture sterilization, resident microsurgery course assessment) through Minimally Invasive Pediatric Surgery Center, Rainbow research awards, Case Western Reserve University PFI Funding (for I-Strab Objective Strabismus Measurement Device), Ohio Amblyope Registry (An organization that fights amblyopia in state level) and UH Innovation day award for his new designed eye speculum. He holds a patent for a novel glaucoma device and also filed several patents on drug delivery, eye imaging, wound healing and other therapeutic technologies.
Since he has joined our faculty, pediatric ophthalmology research has bloomed in not only at a local level (within the division as well as combined research with neonatology, neurology, neurosurgery, oncology, etc), but also regionally (is the Co-PI for the design and evaluation of a ROP screening device in collaboration with NASA, Case, UH and UH Rainbow; A member of Ohio Amblyope Registry); nationally (NEI funded PEDIG – pediatric eye disease investigation group, has finished two and is leading six studies with this group; pharmaceutical studies with Alcon, Bausch and Laumb).
Other Notable Achievements
Dr. Örge is involved regionally and nationally in his field. He gave lectures in the Cleveland Ophthalmological Society meetings in the last four years. He has presented more than 50 papers in AAO, AAPOS, ARVO, Pediatric meetings, as well as international meetings (World Pediatric ophthalmology congress, International Strabismus Association, National Turkish Ophthalmic Society meetings). Due to his activities in the AAPOS, he was invited as the youngest member for the Long Range Planning Retreat. This retreat is gathered every 4-5 years, with only 14 selected members (6 past presidents) to set future direction of the organization.
Dr. Örge is recognized as a young future leader. He was among the recently chosen group for the University Hospitals Leadership Development Program to better his leadership skills and completed his training last year.
Dr. Örge graduated from the University Hospitals and a separate UH Rainbow Babies & Children’s Hospital Leadership Development Program in 2012 and 2018 and was a member of the AAO Leadership Development Program 2015 class. He currently serves as the vice president of the International Pediatric Ophthalmology and Strabismus Council, the international supra-organization that has representatives from more than 80 countries. Through this Council he is helping to align international educational efforts, and align efforts and focus on various pediatric eye disease worldwide. Dr. Örge sees patients at our Landerhaven and Westlake locations, and the UH Rainbow Center for Women & Children.
- Adult Strabismus
- Childhood Strabismus
- Children's Eyes
- Comprehensive Ophthalmology
- Crossed Eyes (Strabismus)
- Droopy Eyes (Ptosis)
- Lazy Eye (Amblyopia)
- Pediatric Cataract
- Pediatric Glaucoma
- Retinopathy of Prematurity (ROP)
- Sports Injuries
UH Rainbow Center for Women and Children
5805 Euclid Ave
Cleveland OH, 44103
University Suburban Health Center
1611 S Green Rd
South Euclid OH, 44121
UH Landerbrook Health Center
5850 Landerbrook Dr
Mayfield Heights OH, 44124
Patient Satisfaction Reviews
4.7 out of 5
- Ophthalmology - American Board of Ophthalmology
Fellowship | Pediatric Ophthalmology
Pediatric Ophthalmology - Indiana University Hospital (2004 - 2005)
Residency | Ophthalmology
Ophthalmology - Indiana University Hospital (2001 - 2004)
Internship | General Surgery
General Surgery - Indiana University Hospital (2000 - 2001)
Research Fellowship | Ophthalmology
Ophthalmology - Indiana University Hospital (1998 - 2000)
Trakya Universitesi (1996)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Faruk Orge did not disclose any Outside Relationships with Industry.